Company registration number 04996548 (England and Wales)
BOGNOR REGIS HEALTH LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 OCTOBER 2023
PAGES FOR FILING WITH REGISTRAR
10 Bridge Street
Christchurch
Dorset
BH23 1EF
BOGNOR REGIS HEALTH LIMITED
CONTENTS
Page
Company information
1
Balance sheet
2 - 3
Notes to the financial statements
4 - 6
BOGNOR REGIS HEALTH LIMITED
COMPANY INFORMATION
- 1 -
Director
Dr. P Spurrier
Company number
04996548
Registered office
3 Acorn Business Centre
Northarbour Road
Cosham
Portsmouth
Hampshire
United Kingdom
PO6 3TH
Accountants
TC Group
10 Bridge Street
Christchurch
Dorset
BH23 1EF
BOGNOR REGIS HEALTH LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2023
31 October 2023
- 2 -
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
3
602
753
Current assets
Debtors
4
1,592
-
0
Cash at bank and in hand
120,886
143,547
122,478
143,547
Creditors: amounts falling due within one year
5
(1,110)
(2,465)
Net current assets
121,368
141,082
Total assets less current liabilities
121,970
141,835
Capital and reserves
Called up share capital
1,000
1,000
Profit and loss reserves
120,970
140,835
Total equity
121,970
141,835
BOGNOR REGIS HEALTH LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 OCTOBER 2023
31 October 2023
- 3 -

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 12 March 2024
Dr. P Spurrier
Director
Company Registration No. 04996548
The notes on pages 4 to 6 form part of these financial statements
BOGNOR REGIS HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023
- 4 -
1
Accounting policies
Company information

Bognor Regis Health Limited is a private company limited by shares incorporated in England and Wales. The registered office is 3 Acorn Business Centre, Northarbour Road, Cosham, Portsmouth, Hampshire, United Kingdom, PO6 3TH.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest pound.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover represents amounts received from clients and speakers fees. It is recognised at the point at which the service is provided.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Office equipment
20% reducing balance
1.4
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

BOGNOR REGIS HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2023
- 5 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
-
0
-
0
3
Tangible fixed assets
Office equipment
£
Cost
At 1 November 2022 and 31 October 2023
2,474
Depreciation and impairment
At 1 November 2022
1,721
Depreciation charged in the year
151
At 31 October 2023
1,872
Carrying amount
At 31 October 2023
602
At 31 October 2022
753
4
Debtors
2023
2022
Amounts falling due within one year:
£
£
Corporation tax recoverable
204
-
0
Other debtors
1,388
-
0
1,592
-
0
BOGNOR REGIS HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2023
- 6 -
5
Creditors: amounts falling due within one year
2023
2022
£
£
Other taxation and social security
-
0
205
Other creditors
1,110
2,260
1,110
2,465
2023-10-312022-11-01false12 March 2024CCH SoftwareCCH Accounts Production 2023.300No description of principal activityDr. P Spurrierfalse049965482022-11-012023-10-3104996548bus:Director12022-11-012023-10-3104996548bus:RegisteredOffice2022-11-012023-10-31049965482023-10-31049965482022-10-3104996548core:FurnitureFittings2023-10-3104996548core:FurnitureFittings2022-10-3104996548core:CurrentFinancialInstrumentscore:WithinOneYear2023-10-3104996548core:CurrentFinancialInstrumentscore:WithinOneYear2022-10-3104996548core:CurrentFinancialInstruments2023-10-3104996548core:CurrentFinancialInstruments2022-10-3104996548core:ShareCapital2023-10-3104996548core:ShareCapital2022-10-3104996548core:RetainedEarningsAccumulatedLosses2023-10-3104996548core:RetainedEarningsAccumulatedLosses2022-10-3104996548core:FurnitureFittings2022-11-012023-10-31049965482021-11-012022-10-3104996548core:FurnitureFittings2022-10-3104996548bus:PrivateLimitedCompanyLtd2022-11-012023-10-3104996548bus:SmallCompaniesRegimeForAccounts2022-11-012023-10-3104996548bus:FRS1022022-11-012023-10-3104996548bus:AuditExemptWithAccountantsReport2022-11-012023-10-3104996548bus:FullAccounts2022-11-012023-10-31xbrli:purexbrli:sharesiso4217:GBP